Fatal amrinone overdose in a pediatric patient.

[1]  S. Lawless,et al.  Effect of Continuous Arteriovenous Haemofiltration on Pharmacokinetics of Amrinone , 1993, Clinical Pharmacokinetics.

[2]  H. Gelband,et al.  Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications. , 1993, Journal of the American College of Cardiology.

[3]  A. Zaritsky,et al.  Simplified Assay of Amrinone in Plasma by High‐Performance Liquid Chromatography , 1990, Therapeutic drug monitoring.

[4]  S. Lawless,et al.  Amrinone in neonates and infants after cardiac surgery. , 1989, Critical care medicine.

[5]  W. Diven,et al.  Amrinone Pharmacokinetics in Neonates and Infants , 1988, Journal of clinical pharmacology.

[6]  R. Ascuitto,et al.  Negative Inotropic Effects of Amrinone in the Neonatal Piglet Heart , 1987, Circulation research.

[7]  P. Baele,et al.  Amrinone in the management of low cardiac output after open heart surgery. , 1985, The American journal of cardiology.

[8]  G. Treadway.  Clinical safety of intravenous amrinone--a review. , 1985, The American journal of cardiology.

[9]  R. N. Brogden,et al.  Amrinone. A preliminary review of its pharmacological properties and therapeutic use. , 1983, Drugs.

[10]  M. Rosen,et al.  Developmental changes in the cardiac effects of amrinone in the dog. , 1983, Circulation research.

[11]  M. Webb-Peploe,et al.  Side effects of amrinone therapy. , 1983, British heart journal.

[12]  E. Blackstone,et al.  Cardiac performance and mortality early after intracardiac surgery in infants and young children. , 1975, Circulation.